Brief: Addex Starts Phase 2 Clinical Study Of ADX71149 For Epilepsy

Addex Therapeutics

07/06/2021 06:02

June 7 (Reuters) - ADDEX THERAPEUTICS LTD  ADXN.S :
    * STARTS PHASE 2 CLINICAL STUDY OF ADX71149 FOR EPILEPSY
    * DATA FROM STUDY ARE EXPECTED IN Q3 2022

Source text for Eikon:  ID:nGNEbp6FBc 
Further company coverage:  ADXN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))